Harpoon Therapeutics

$10.81 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Harpoon Therapeutics

Harpoon Therapeutics, Inc. operates as a biotechnology company. The Company develops novel class T cell that unleash the natural power of the T cells to fight cancer and other diseases. Harpoon Therapeutics serves patients in the States of Massachusetts and California.

Stock Analysis

last close $11.49
1-mo return -23.8%
3-mo return -44%
avg daily vol. 453.2T
52-week high 25.24
52-week low 10.55
market cap. $374M
forward pe -
annual div. -
roe -106.7%
ltg forecast -
dividend yield -
annual rev. $23M
inst own. 82.6%

Subscribe now for daily local and international financial news